Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label.

Details

Language :

English

ISSN :

0954691X

Volume :

33

Issue :

1

Database :

Complementary Index

Journal :

European Journal of Gastroenterology & Hepatology

Publication Type :

Academic Journal

Accession number :

147311988

Full Text :

https://doi.org/10.1097/MEG.0000000000001843